Literature DB >> 9024333

Treatment strategies for agitation and psychosis in dementia.

P N Tariot1.   

Abstract

Agitation or psychosis or both occur in half or more of patients with dementia at some point during the course of illness. The treatment of these signs and symptoms ideally entails identification and alteration of physical, environmental, social, and psychiatric factors. Environmental modification, education of caregivers, and therapeutic activity programs are nonpharmacologic approaches that can effectively reduce some signs and symptoms of this nature. For those that remain, empirical administration of pharmacologic agents may be appropriate. One approach is to inventory the specific behaviors and develop a "therapeutic metaphor," i.e., subtype the agitated behaviors according to the presence of target symptoms likely to respond to specific classes of medication. Available evidence is reviewed regarding the efficacy and safety of somatic therapies for agitation, including antipsychotics, antidepressants, anticonvulsants, benzodiazepines, and cholinesterase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9024333

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

Review 1.  Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia.

Authors:  M E Hemels; K L Lanctôt; M Iskedjian; T R Einarson
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Effect of divalproex sodium on behavioural and cognitive problems in elderly dementia.

Authors:  Jane M Meinhold; Lesley M Blake; Louis J Mini; Jeffrey A Welge; Michael Schwiers; Anthony Hughes
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.

Authors:  Dong-Churl Suh; Stephen Arcona; Simu K Thomas; Christopher Powers; Adrian L Rabinowicz; Hyunchul Shin; Dario Mirski
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

4.  Recognition and Management of Behavioral Disturbances in Dementia.

Authors:  Abhilash K. Desai; George T. Grossberg
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-06

5.  Impact of Antipsychotics on Geriatric Patients: Efficacy, Dosing, and Compliance.

Authors:  Gerald A. Maguire
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-10

Review 6.  Advances in Management of Neuropsychiatric Syndromes in Neurodegenerative Diseases.

Authors:  Jeffrey Cummings; Aaron Ritter; Kasia Rothenberg
Journal:  Curr Psychiatry Rep       Date:  2019-08-08       Impact factor: 5.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.